David C. Myles - Net Worth and Insider Trading
David C. Myles Net Worth
The estimated net worth of David C. Myles is at least $9 Million dollars as of 2024-11-05. David C. Myles is the CH. DISCOV. & NON-CLIN DEV OFF of Olema Pharmaceuticals inc and owns about 728,945 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $9 Million. Details can be seen in David C. Myles's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David C. Myles has not made any transactions after 2023-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David C. Myles
David C. Myles Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David C. Myles owns 1 companies in total, including Olema Pharmaceuticals inc (OLMA) .
Click here to see the complete history of David C. Myles’s form 4 insider trades.
Insider Ownership Summary of David C. Myles
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2023-11-22 | Chief Development Officer |
David C. Myles Latest Holdings Summary
David C. Myles currently owns a total of 1 stock. David C. Myles owns 728,945 shares of Olema Pharmaceuticals inc (OLMA) as of November 22, 2023, with a value of $9 Million.
Latest Holdings of David C. Myles
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2023-11-22 | 728,945 | 11.90 | 8,670,801 |
Holding Weightings of David C. Myles
David C. Myles Form 4 Trading Tracker
According to the SEC Form 4 filings, David C. Myles has made a total of 5 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 13,629 shares on November 22, 2023, which brought David C. Myles around $196,258.
Insider Trading History of David C. Myles
- 1
David C. Myles Trading Performance
David C. Myles Ownership Network
Ownership Network List of David C. Myles
Ownership Network Relation of David C. Myles
David C. Myles Owned Company Details
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
David C. Myles is the Chief Development Officer of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include 10 percent owner Paradigm Biocapital Advisors Lp , director & Chief Technology Officer Cyrus Harmon , and director & President and CEO Sean Bohen .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, David C. Myles made 4 insider transaction in Olema Pharmaceuticals inc (OLMA) with a net sale of 44,370. Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 2,300,000 shares made by Paradigm Biocapital Advisors Lp , and a net sale of 535,000 shares made by G. Walmsley Graham .
In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,048,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 1,802,142 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
David C. Myles Mailing Address
Above is the net worth, insider trading, and ownership report for David C. Myles. You might contact David C. Myles via mailing address: C/o Olema Pharmaceuticals, Inc., 512 2nd Street, 4th Floor, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
